Abstract-Asymmetrical dimethylarginine inhibits nitric oxide synthase, cationic amino acid transport, and endothelial function. Patients with cardiovascular risk factors often have endothelial dysfunction associated with increased plasma asymmetrical dimethylarginine and markers of reactive oxygen species. We tested the hypothesis that reactive oxygen species, generated by nicotinamide adenine dinucleotide phosphate oxidase, enhance cellular asymmetrical dimethylarginine. Incubation of rat preglomerular vascular smooth muscle cells with angiotensin II doubled the activity of nicotinamide adenine dinucleotide phosphate oxidase but decreased the activities of dimethylarginine dimethylaminohydrolase by 35% and of cationic amino acid transport by 20% and doubled cellular (but not medium) asymmetrical dimethylarginine concentrations (PϽ0.01). This was blocked by tempol or candesartan. Cells stably transfected with p22 phox had a 50% decreased protein expression and activity of dimethylarginine dimethylaminohydrolase despite increased promoter activity and mRNA. The decreased DDAH protein expression and the increased asymmetrical dimethylarginine concentration in p22
A symmetrical dimethylarginine (ADMA) inhibits nitric oxide synthase (NOS) and cationic amino acid transport (CAT). 1 ADMA is generated by protein arginine methyltransferases (PRMTs) and, after proteolysis, cellular ADMA is metabolized by dimethylarginine dimethylaminohydrolases (DDAHs) or exported by CATs. 2, 3 Angiotensin II (Ang II) can generate reactive oxygen species (ROS) in blood vessels by activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. 4 Patients with early hypertension or kidney disease have elevated plasma levels of ADMA and markers of ROS, 5 which may contribute to endothelial dysfunction and subsequent cardiovascular or renal events. Although increased ADMA occurs in several conditions associated with ROS, 6 it is unclear how ROS increase ADMA. Moreover, infusions of Ang II sufficient to increase ROS have variable effects on plasma ADMA. [7] [8] [9] The present studies were designed to test the hypothesis that NADPH oxidase enhances PRMT and/or reduces DDAH, but that a reduction in CAT activity may limit cellular ADMA export. First, we assessed the effects of Ang II on ROS and ADMA in cultured cells. Thereafter, we investigated the mechanism of NADPH oxidase-induced changes in ADMA directly in cells stably transfected with p22 phox which increases NADPH oxidase activity. 10 We selected preglomerular vascular smooth muscle cells (PGVSMCs) because the afferent arteriole is the main resistance vessel in the kidney and generates ROS with Ang II 11 and vascular smooth muscle cells (VSMCs) produce little nitric oxide (NO), which obviates its confounding effects on DDAH activity. 12 
Methods
All animal care and experimental procedures complied with National Institutes of Health guidelines and were approved by Georgetown University Animal Care and Use Committee. Details of the methods
Measurement of Superoxide Production in PGVSMCs
Cells were seeded into a 96-well plate at densities of 1ϫ10 5 cells per well in 200 L of the DMEM-F12 medium. After 24 hours, the cells were incubated overnight in serum-free medium, which was replaced 4 hours before incubation with added vehicle or indicated dose of Ang II. Measurement of superoxide (O 2 ⅐Ϫ ) was as described in detail previously for these cells using low concentration (5 mol/L) lucigenin-enhanced chemiluminescence. 11 NADPH oxidase activity was assessed from the increase in superoxide generated after addition of 100 mol/L of NADPH.
Overexpression of NADPH Oxidase Subunit p22 phox in Rat PGVSMCs
A full-length rat p22 phox cDNA fragment (709 bp) was cloned into the EcoRI/XbaI site of pcDNA4 HisMax vector which contained ampicillin and zeocin-resistant genes to allow positive clone (see the online Data Supplement).
DDAH2 Promoter Activity Assay
The mouse DDAH-2 promoter (Ϫ924 to Ϫ36 bp from transcription start site) that drives a luciferase construct was cloned into pGL3-Basic vector (Promega) as described previously. 13 This was a gift from Dr Satoshi Tanaka (University of Tokyo, Japan) (see the online Data Supplement).
Medium or Cell Lysate ADMA, Symmetrical Dimethylarginine, and L-Arginine
VSMCs were grown to full confluence in 100-mm dishes and cultured for 48 hours in 5 mL of serum-free, phenol red-free medium. Some dishes of cells were directly treated with indicated dose of Ang II for 48 hours and some of them were pretreated for 2 hours with Candesartan (10 Ϫ7 mol/L), CandesartanϩPD-123,319 (3ϫ10 Ϫ6 mol/L) or Tempol (10 Ϫ4 mol/L) and then coincubated with vehicle or Ang II (10 Ϫ6 mol/L) for 48 hours. Measurement of ADMA, symmetrical dimethylarginine (SDMA), and L-arginine in the medium and cell lysate was performed using HPLC as previously described (see the online Data Supplement). 14 
Medium H 2 O 2
Measurement of H 2 O 2 released from intact PGVSMCs was performed using Amplex Red hydrogen peroxide/peroxidase assay kit (Molecular Probes Inc) (see the online Data Supplement).
DDAH Activity
The conversion of [
14 C]ADMA to [ 14 C]citrulline was used to quantify DDAH activity based on previous assays (see the online Data Supplement). 15 
CAT Activity Assays
CAT activity was assessed in intact cells from 10 mmol/L lysineinhibitable [ 14 C]ADMA uptake (see the online Data Supplement). 2
RNA Isolation and Real-Time Quantitative RT-PCR
Real-time quantitative PCR was performed in an ABI Prism 7700 sequence-detection system (Applied Biosystems, Foster City, Calif) as described (see the online Data Supplement). 16 
Protein Expression
This used Western blot as described (see the online Data Supplement). 16 
Analysis of Protein Carbonylation
The carbonylated proteins from lysed cells were detected with an OxyBlot Oxidized Protein Detection Kit (Millipore, Billerica, Mass) as reported previously (see the online Data Supplement). 17 
Materials
Ang II, tempol, and NADPH were obtained from Sigma-Aldrich (St Louis, Mo), DMEM-F12 from Gibco (Carlsband, Calif), and FBS from American Type Culture Collection (Manassas, VA).
Statistical Analysis
Results are expressed as meansϮSEM. ANOVA was performed, and differences between experimental groups were compared by Student's t test, when appropriate. A value of PϽ0.05 was considered as statistically significant.
Results
Ang II produced concentration-dependent increases in cellular O 2 ⅐Ϫ from 10 Ϫ10 mol/L ( Figure 1A ), confirming prior findings. 11 Cellular ADMA doubled with 10 Ϫ6 mol/L Ang II, but the medium ADMA was modestly reduced ( Figure 1B) . Coincubation of Ang II-stimulated cells with candesartan or tempol reduced cellular ADMA ( Figure 1C ), which was not altered by addition of the Ang II type 2 (AT 2 ) receptor blocker PD-123,319. Ang II increased the activity of NADPH oxidase (2-fold; PϽ0.01; Figure 2A ) but decreased the activities of DDAH by 35% (PϽ0.01) and CAT by 20% (PϽ0.05) ( Figure 2B and 2C) .
Cells stably transfected with p22 phox (S-p22 phox ) had an increased expression of NOX-1 mRNA (2.4Ϯ0.37-fold; PϽ0.02) and protein (2.9Ϯ0.1-fold; PϽ0.003) but no significant changes for NOX-4 ( Figure S1 in the online Data Supplement). Transcripts or protein for NOS-1, -2, or -3 were not detected in PGVSMCs (data not shown). The S-p22 phox cells had a 2.5-fold increased p22 phox (PϽ0.01) and a 2-fold increased O 2 ⅐Ϫ and H 2 O 2 (PϽ0.01; Figure 3 ). The mRNA for DDAH-1 and DDAH-2 ( Figure 4A ) and the DDAH-2 promoter activity ( Figure 4B ) were increased by 2-to 4-fold (PϽ0.01) in S-p22 phox cells. However, the protein expression for DDAH-1 and DDAH-2 were reduced by 50% (PϽ0.01; Figure 4C ), and the DDAH activity was reduced correspondingly (PϽ0.01; Figure 4D ). S-p22 phox cells had a marked increase in protein carbonyls that was abolished by incubation with catalase and tempol ( Figure S2 ). After incubation of S-p22 phox cells with 1 mol/L epoxomicin to inhibit proteosomal degradation, DDAH-1 and -2 expression increased by 50% (PϽ0.05; Figure S3 ). This was accompanied by a reduction in cellular concentrations of ADMA in S-p22 S-p22 phox cells grown in culture medium containing L-arginine had a 10% increase in medium L-arginine concentration (PϽ0.005), a 60% increase in medium ADMA (PϽ0.005) and a 5% reduction in medium SDMA (PϽ0.05; Table) . The concentrations in cell water were calculated from the relationship between cell water and cell protein content in rat cultured VSMCs. 18 S-p22 phox cells had a doubling of cellular L-arginine (PϽ0.005), a 2.6-fold increase in cellular ADMA (PϽ0.005), and a 3-fold increase in cellular SDMA (PϽ0.05; Table) . The cell:medium concentration ratio for L-arginine, ADMA, and SDMA were all increased significantly (PϽ0.05) in S-p22 phox cells (Table) .
Discussion
The main new findings are: Incubation of VSMCs with Ang II for 4 hours increased O 2 ⅐Ϫ and cellular, but not medium, ADMA. Inhibition of AT 1 receptors or ROS blocked the increase in cellular ADMA. Ang II stimulated NADPH oxidase but inhibited DDAH and CAT activities. Stable transfection of cells with p22 phox increased mRNA and protein expression for NOX-1 and increased the ROS generation, protein arginine methylation, and PRMT-3 expression but decreased DDAH protein expression and activity, CAT activity and CAT-1 expression. The decrease in DDAH protein and activity occurred despite an increase in DDAH mRNA expression and was prevented by blockade of proteosomal degradation which also reduced cellular ADMA of S-p22 phox cells to the level of Wt cells. These changes in S-p22 phox cells were accompanied by an increase in medium and a greater increase in cellular levels of ADMA.
The function of ADMA in VSMCs is not clear. We could not detect expression of mRNA or protein for any NOS isoform in our isolated PGVSMCs. However, ADMA can have adverse vascular effects in endothelial nitric oxide synthase knockout mice. 19 ADMA can stimulate ROS production from some NOS isoforms if arginine is limited or tetrahydrobiopterin is oxidized. 20 Moreover, Vallance and Leiper 1 have shown that ADMA released from 1 cell can inhibit NOS in an adjacent cell and that this could be a mechanism for VSMCs to signal to endothelial cells. Additionally, Ang II doubled the release of ADMA from cultured endothelial cells. 21 Thus, a similar mechanism for angiotensin-induced ADMA generation may occur in VSMCs and endothelial cells, but this remains to be explored.
We found an increase in cellular ADMA with Ang II that was related to AT 1 receptor activation and to ROS. Thus, cellular O 2 ⅐Ϫ and ADMA increased in parallel from 10
Ϫ10
mol/L Ang II and the increase in ADMA was prevented by candesartan, but not PD-123,319 and by tempol, which prevented Ang II-stimulated increases in O 2 ⅐Ϫ in these cells. 11 A decreased ADMA metabolism by DDAH during Ang II could contribute to increased cellular ADMA concentrations, whereas a decreased CAT activity could reduce cellular export of ADMA into the medium. Further studies focused on the direct effects of prolonged NADPH oxidase activity on ADMA.
The membrane protein p22 phox is a critical component of NADPH oxidase. 10 Smooth muscle specific overexpression of p22 phox in mice increased aortic p22 phox and NOX-1 proteins and increased O 2 ⅐Ϫ and H 2 O 2 generation, 22 whereas knockdown of p22 phox in vivo reduced the protein expression for NOX-1, -2, and -4. 23 Stable transfection of cells with p22 phox provided a robust model of cellular oxidative stress with increased O 2 ⅐Ϫ and H 2 O 2 generation and increased NOX-1 expression. In apparent contrast to the finding that Ang II decreased DDAH activity in PGVSMCs, we detected an increase in the mRNA for DDAH-1 and -2 in S-p22 phox cells accompanied by an increase in the promoter activity for DDAH-2. However, this was accompanied by a reduction in protein expression for DDAH-1 and -2 and cellular DDAH activity. This discrepancy was related to enhanced proteosomal degradation because the reduced protein expression for DDAH-1 and -2 in S-p22 phox cells was mitigated (for DDAH-1) or prevented (for DDAH-2) by inhibition of proteosomal degradation by epoxomicin, which also normalized the increased cellular ADMA concentrations. This extended prior studies in which H 2 O 2 enhanced proteosomal degradation of the inositol 1,4,5-triphosphate receptor in VSMCs. 24 Because restoration of DDAH-1 or -2 protein expression with epoxomicin did not correct the increased mRNA in S-p22 phox cells, the increased mRNA was not likely a compensation for reduced DDAH expression.
Inhibition of DDAH by oxidative stress has been ascribed to oxidation of a cysteine residue in the catalytic site of the enzyme 1, 12 or to downregulation of protein expression. 25 A novel finding was that this also can involve proteosomal degradation of the DDAH protein. We detected increased asymmetrical dimethylarginine in proteins and increased PRMT-3 protein 26 reported that bovine retinal capillary endothelial cells cultured in high-glucose solution that elevated ROS production had increased PRMT-1 expression and decreased DDAH activity and DDAH-2 expression. These were corrected by antioxidants, suggesting that ROS increased PRMT-1 and decreased DDAH, as in our study.
The finding that Ang II or activation of NADPH oxidase reduced cellular CAT activity and that the latter reduced CAT-1 mRNA expression is compatible with prior studies that have reported diminished CAT activity or expression under conditions that induce oxidative stress, for example, exposure to cigarette smoke 27 or homocysteine. 28 ADMA concentrations in cultured endothelial cells are reported to be Ϸ10-fold above that in the medium. 29 We measured ADMA concentrations in PGVSMCs to be 27-fold above that in the medium. The calculated intracellular concentrations of ADMA of 6 mol/L in Wt cells and 16 mol/L in S-p22 phox cells are expected to inhibit NOS in other cell types that express NOS isoforms, but the higher calculated intracellular arginine concentrations would offset this effect. The doubling of intracellular L-arginine in p22 phox cells may be secondary to increased cellular proliferation which enhances arginine turnover 30 because p22 phox overexpression induces proliferation in VSMCs. 10 
Perspectives
Because Ang II upregulated ROS in many tissues 4, 11 and ROS increased cellular ADMA, Ang II should increase ADMA. Indeed, Ang II doubled ADMA release from cultured endothelial cells. However, we found that relatively short-term incubation of VSMCs with Ang II for 4 hours did not change, or even reduced, medium ADMA, despite a rise in cellular ADMA. This may be a consequence of a reduced CAT activity which could slow the cellular export of ADMA. Infusions of Ang II were reported to increase 7 or maintain 8 plasma ADMA or to increase ADMA only at high rates of Ang II infusion. 9 Our findings in isolated cells suggest that there could be a substantial increase in cellular ADMA in conditions that enhance ROS that may not be reflected reliably in plasma levels because of decreased CAT activity. The finding that Ang II and NADPH oxidase expression both reduced CAT activity supports the possibility that in the short term, ADMA export may be diminished. However, in the long term, the increased intracellular ADMA will stress the CAT system and export will increase until a new steady state has been reached where the rate of ADMA production will equal the sum of degradation by DDAH and export by CAT. 2 The main effect of CAT inhibition is that this steady state should be reached at higher intracellular levels of ADMA. ADMA production in S-p22 phox cells was increased, as evidenced by increased PRMT expression and increased levels of ADMA moieties on proteins. From the Table, it is apparent that ADMA in the medium increased 1.6-fold compared to wild-type cells. This is less than the 2.7-fold increase in intracellular ADMA, compatible with reduced CAT activity, but clearly shows an increased net export of ADMA. Thus, under steady-state conditions, export of ADMA by VSMCs may be increased by ROS, although this may not hold for other cell types. Uptake of ADMA by neighboring endothelial cells with NOS inhibition is plausible, but remains to be demonstrated experimentally. 
ONLINE DATA SUPPLEMENT ANGIOTENSIN II AND NADPH OXIDASE INCREASE ADMA IN VASCULAR SMOOTH MUSCLE CELLS

Methods
Cell culture: The phenotype of the cells was confirmed from characteristic morphology (hill and valley pattern), Ang II contraction, expression of smooth muscle-specific alpha actin and smooth muscle myosin heavy chain and the absence of mRNA for von Willebrand factor (endothelial cell marker). Experiments were conducted between passages 4 and 12. Cells were cultured in DMEM-F12 medium supplemented with 10% fetal bovine serum, 100 u · ml After incubation for 20 min at room temperature, the complex was added to 60-70% confluent PGVSMCs seeded in a 60mm plate in 5ml of Opti-MEM I reduced serum medium. After incubation at 37ºC for 6h, transfected cells were cultured in DMEM/F-12 medium containing 15% fetal bovine serum. 48 hours later, transfected cells were split 1:4 into 100-mm plates and cultured in regular growth medium with 450µg · ml 
DDAH2 promoter activity assay:
The plasmid construction, transfection and DDAH-2 promoter activity assay were described previously and incubated in culture medium for 24 h. Cells were transiently transfected with the plasmid DNA or promoter lacking pGI3-basic vector using lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Cells were incubated for 48 hours and harvested in passive lysis buffer (Promega, Madison, WI). Luciferase activity was measured with luciferase assay substrate and normalized by cellular protein concentrations (protein assay reagent; Bio-Rad Laboratories, Inc., Hercules, CA). Each sample was examined in triplicate, and at least three independent experiments were performed.
Medium or cell lysate ADMA, SDMA, and L-arginine: After 48-hour of cell culture in serum-free, phenol-red-free medium, the conditioned medium was collected in a 15ml sterile polypropylene tube and centrifuged at 4°C for 10 min at 2000g , thereafter the supernatant was transferred to ice cold 1.5 ml tubes and stored at -80 °C. Cells were washed three times with icecold PBS, scraped into 5 ml of ice-cold PBS and centrifuged at 500g for 5 min. The pellet was resuspended in 250 µl of ice-cold sodium phosphate buffer (100 mM; pH 6.5) on ice for 30 min, sonicated on ice with 3 sets of 10 second pulses using a Sonifier Sonicator 250 (Branson; Danbury CT, USA; output 3.0, duty cycle 30%), mixed with 250 μl of 1.2 M perchloric acid (Sigma, St. Louis, MO) and, after centrifugation (10 minutes at 2,000 g at 4ºC), the supernatant was collected and stored at -80 ºC. Concentrations of L-arginine, ADMA and SDMA in medium 2 and lysate were measured by HPLC with fluorescence detection as previously described 2 using modified chromatographic separation conditions 3 . Supernatants obtained after deproteinization of cell lysates with perchloric acid were neutralized with two volumes of 0.5 M Na 2 HPO 4 to one volume of the supernatant. Cell lysates and medium were spiked with monomethylarginine as an internal standard and purified by solid-phase extraction on polymeric cation-exchange columns. Thereafter, the samples were dried with nitrogen, and derivatized with ortho-phthaldialdehyde reagent containing 3-mercaptopropionic acid. Analytes were separated by isocratic reversedphase HPLC with fluorescence detection. A human plasma pool was analyzed in all analytical series as a quality control. For all analytes the intra-and inter-assay coefficients of variation were <1.5% and <3.5%, respectively. Lysate concentrations were normalized to protein content. 
Medium
